Team and cross-functional exchange and ideation are very valuable and deeply rooted in Novo Nordisk's corporate culture. We are pleased that we can use a specially designed creative space for these meetings.
Updated: May 2025
95%
of employees say this is a great place to work
Novo Nordisk is a world-leading pharmaceutical company founded in 1923 and headquartered in Denmark. We are driving change with the ambition to conquer diabetes and other serious chronic diseases such as obesity and rare blood and metabolic disorders. We have been pioneering and researching innovative solutions to prevent and cure diseases for 100 years. We promote access to our products for patients worldwide and are actively committed to prevention. As a sustainable company, we pursue the goal of zero environmental impact in all our business activities with our "Circular for Zero" environmental strategy. We are the first pharmaceutical company to run global production on 100% from renewable energy since 2020. Novo Nordisk employs around 53,000 people in 80 countries and sells its products in around 170 countries. The first subsidiary outside Denmark was founded in Switzerland in 1930. Today, around 250 employees work at the Zurich Airport site, around a third of them for the Swiss subsidiary.
(Zurich)
Certification January 2023
Certification March 2020
Certification January 2023
Certification March 2020
Team and cross-functional exchange and ideation are very valuable and deeply rooted in Novo Nordisk's corporate culture. We are pleased that we can use a specially designed creative space for these meetings.
As a leading pharmaceutical company with a hundred-year history, we have pursued one mission since our foundation: to conquer serious chronic diseases. Together, we can bring about major changes if we are open to innovation and progress. Our employees can contribute to change independently and creatively. We want them to develop their potential, their enthusiasm, their different perspectives and individual skills in the best possible way with us. This is the only way we can continue to grow and develop.
Anne Mette Wiis Vogelsang
General Manager & CVP
For 100 years, we have been meeting the needs of people with serious chronic diseases with innovative medicines and injection systems such as insulin pens. By combining innovation and pharmacological excellence, we use the experience and insights of patients and partners to transform bold ideas into life-saving and preventive medicines. The talent, passion and personal experience of our employees are the foundation of our success.
Image copyright: © Flughafen Zürich AG
You are currently viewing placeholder content from Vimeo. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing placeholder content from reCAPTCHA. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information
